About CosmosID
CosmosID is a company based in Rockville (United States) founded in 2008. CosmosID has raised $7.32 million across 4 funding rounds from investors including Plug and Play Tech Center and Applied Value Group. CosmosID offers products and services including Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing. CosmosID operates in a competitive market with competitors including Trace Genomics, Kallyope, AnimalBiome, Macrogen and Microbiotica, among others.
- Headquarter Rockville, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cosmosid, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.32 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Plug and Play Tech Center
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CosmosID
CosmosID offers a comprehensive portfolio of products and services, including Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing.
Cost-effective profiling of microbial communities for taxonomic analysis.
Delivers detailed microbiome data through whole genome sequencing.
Enables species-level resolution for large cohort microbiome studies.
Identifies complete genetic makeup of bacterial isolates for diversity insights.
People of CosmosID
Unlock access to complete
Unlock access to complete
Funding Insights of CosmosID
CosmosID has successfully raised a total of $7.32M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CosmosID
CosmosID has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Plug and Play Tech Center and Applied Value Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated and invested in across multiple tech sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CosmosID
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CosmosID
Investment portfolio details for CosmosID
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CosmosID
Detailed financials for CosmosID
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cosmosid Comparisons
Peer comparison for CosmosID
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CosmosID
CosmosID operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Kallyope, AnimalBiome, Macrogen and Microbiotica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of technologies to diagnose soil health and soil-borne disease prediction
|
|
| Locked | Locked | Locked |
The gut-brain axis is explored for therapeutic and nutritional innovations.
|
|
| Locked | Locked | Locked |
Animal microbiome diagnostics services for pet care are offered.
|
|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Live bacterial therapeutics and biomarkers are developed for multiple diseases.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
Detailed competitors of CosmosID
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cosmosid
Complete news archive for CosmosID
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CosmosID
CosmosID was founded in 2008 and raised its 1st funding round 3 years after it was founded.
CosmosID is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.
CosmosID is a funded company, having raised a total of $7.32M across 4 funding rounds to date.
CosmosID was founded in 2008 and is based in Rockville, United States. Next-generation sequencing technologies are developed by the company for the detection of microorganisms in the biotechnology sector. The GENIUS software suite is utilized, which incorporates a curated genome database and proprietary algorithms to enable bacterial identification at the species, subspecies, or strain level. Operations focus on rapid analysis, with results typically available in minutes.
CosmosID's top competitors include Trace Genomics, BGI and Kallyope.
CosmosID offers Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing.
CosmosID has 2 investors. Key investors include Plug and Play Tech Center, and Applied Value Group.